P15.02: Incidences of fetofetal transfusion syndrome and perinatal outcomes in triplet gestations with monochorionic placentation
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
The aim of this study was to determine the incidences of fetofetal transfusion syndrome (FFTS) and perinatal outcomes in triplet gestations with monochorionic placentation. In this retrospective cohort study, we evaluated the incidences of FFTS and perinatal outcomes at 28 days of age in triplet gestations with monochorionic placentation who were managed before 16 weeks of gestation and delivered at one of four perinatal care centres. In the 41 triplets (n = 17, monochorionic triamniotic; n = 22, dichorionic triamniotic; n = 1, dichorionic diamniotic; and n = 1, monochorionic monoamniotic), the incidence of FFTS was 17.1% and the median gestational age at FFTS diagnosis was 19 weeks. Laser therapy was performed in four cases. In 123 triplets, the incidences of fetal death and neonatal death at 28 days of age were 8.1% and 0.9%, respectively. Intraventricular hemorrhage did not occur in any neonate, while cystic periventricular leukomalacia occurred in 6 infants (5.3%, 6/113). The incidence of poor outcomes at 28 days of age was 13.8%. The incidences of FFTS and poor perinatal outcome at 28 days were approximately 17% and 14%, respectively. Therefore, triplet gestations with monochorionic placentation should be managed intensively.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- P15.02: Incidences of fetofetal transfusion syndrome and perinatal outcomes in triplet gestations with monochorionic placentation
- Date Crossref
- 01/09/2015
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Osaka International Cancer Institute pays non établi dans la noticeStructure de recherche
-
Seirei Hamamatsu General Hospital Maternal and Perinatal Care Center pays non établi dans la noticeÉtablissement de santé
-
Kobe Children's Hospital Obstetrics pays non établi dans la noticeÉtablissement de santé
-
Tokushima University Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Department of Maternal‐Fetal Medicine Osaka Medical Center and Research Institute for Maternal and Child Health Izumi Japan Department of Maternal-Fetal Medicine pays non établi dans la noticeStructure de recherche
Osaka International Cancer Institute, Maternal and Perinatal Care Center — Seirei Hamamatsu General Hospital et Obstetrics — Kobe Children's Hospital, avec 2 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.